Mdma molecule:

Image from PubChem

Mdma Clinical Trials

Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)

To see complete record on, please visit this link

Id: NCT00895804

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Completed

Start Date: June 2001

Last Update: June 15, 2009

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: MDMA (3,4-Methylenedioxymethamphetamine, "Ecstasy") produces tachycardia, hypertension, hyperthermia, and other acute adverse effects. Ecstasy use has also been associated with rare cardio- and cerebrovascular complications. The role of beta-blockers in the treatment of cardiovascular and adverse effects of MDMA is unknown.

  • Mood Disorder
  • Substance-Related Disorders
  • Amphetamine-Related Disorders

Total execution time in seconds: 0.2002010345459